Jubilant Pharma inks vaccine manufacturing agreement with US for $149.6 M
The agreement will enable the company to double its injectable filling production capacity at a total cost of $193 million, at its Spokane, Washington manufacturing facility
Stay updated with breaking news from Army Contracting Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The agreement will enable the company to double its injectable filling production capacity at a total cost of $193 million, at its Spokane, Washington manufacturing facility
/PRNewswire/ -- Jubilant Pharmova Limited has announced today that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly...
DOD to fund planned manufacturing expansion and to prepare the U.S. for a rapid response to the next pandemic as part of Industrial Base Expansion...
Awards recognize everyday heroes making a difference for employees with disabilitiesVIENNA, Va., May 11, 2022 /PRNewswire/ -- SourceAmerica®, a le...
Grand River Aseptic Manufacturing (“GRAM”), a leading parenteral contract development and manufacturing organization (CDMO), has signed a...